BackFuse Medical Overview

Fuse Medical Profit Margin

Valuation check: FZMD's profit margin is 19.72%, above the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

6.16%
↑ 407.91% YoY

As of Jun 2023

Annual Profit Margin (TTM)

19.72%
↑ 356.71% YoY

Trailing 12 months ending Jun 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Fuse Medical (FZMD) FAQ

Fuse Medical (FZMD) currently reports a profit margin of 19.72% as of June 2023. That compares with -7.68% in the prior-year period — up 356.7% year over year. That is above the sector sector average of 13.4%. Use the charts on this page to explore Fuse Medical's profit margin history and peer comparisons.

Fuse Medical's profit margin increased from -7.68% to 19.72% — a 356.7% year-over-year increase (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fuse Medical's profit margin of 19.72% is higher than the its sector sector average of 13.4%. That is roughly 47.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Fuse Medical's current 19.72% should be judged against industry norms (sector average: 13.4%) and against FZMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 19.72%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for Fuse Medical, and consider following FZMD for alerts when major investors trade the stock.